CLOs on the Move

Alliance Homecare

www.alliancehomecare.com

 
Alliance Homecare is a private home healthcare company offering an extensive range of services, including Private Duty Nursing, Home Health Aides, and Geriatric Care Management. As a Licensed Home Care Services Agency (LHCSA), we cater to a sophisticated client base in the New York metropolitan area. We staff only the highest quality Registered Nurses, Home Health Aides, and healthcare professionals. These individuals understand that our clients expect the very best talent in home care. Our company is committed to providing world class care to our patients and their loved ones while honoring a strict code of confidentiality. We offer an ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.

Symbion Research International

Symbion Research International is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Protech Dental Studio

Protech Dental Studio is a Sterling, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.

Share Medical Center

Share Medical Center is committed to the development of our staff.